Undervalued Relief Therapeutics (RLFTF) is gaining traction
Relief Therapeutics (OTC:RLFTF) is set for an upcoming boom. The company is developing a therapeutic drug for COVID-19 lung injury and I think that this stock is undervalued. The company having done really well in the last couple months saw…